Evidence map›Paper›PMID 26530182›Full record

Trial reportBMC cancer2015

Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma.

David Bird, Andrew F Scarsbrook, Jonathan Sykes, Satiavani Ramasamy, Manil Subesinghe, Brendan Carey, Daniel J Wilson, Neil Roberts, Gary McDermott, Ebru Karakaya and 4 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 58 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

David BirdDepartment of Radiotherapy Physics, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK. david.bird3@nhs.net.
Andrew F ScarsbrookDepartment of Nuclear Medicine, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK. a.scarsbrook@nhs.net.
Jonathan SykesDepartment of Radiotherapy Physics, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK. sykesjonr@googlemail.com.
Satiavani RamasamyDepartment of Clinical Oncology, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett Street, LS9 7TF, Leeds, UK. van.ramasamy@gmail.com.
Manil SubesingheDepartment of Nuclear Medicine, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK. manil.subesinghe@gmail.com.
Brendan CareyDepartment of Clinical Radiology, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK. Brendan.carey@nhs.net.
Daniel J WilsonDepartment of Medical Physics, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK. djw@medphysics.leeds.ac.uk.
Neil RobertsDepartment of Radiotherapy, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK. neil.roberts7@nhs.net.
Gary McDermottDepartment of Medical Physics, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK. garry.mcdermott@nhs.net.
Ebru KarakayaDepartment of Clinical Oncology, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett Street, LS9 7TF, Leeds, UK. ebruzey2007@gmail.com.
Evrim BaymanDepartment of Clinical Oncology, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett Street, LS9 7TF, Leeds, UK. evrim.bayman@hotmail.com.
Mehmet SenDepartment of Clinical Oncology, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett Street, LS9 7TF, Leeds, UK. Mehmet.sen@nhs.net.
Richard SpeightDepartment of Radiotherapy Physics, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK. Richard.speight@nhs.net.
Robin J D PrestwichDepartment of Clinical Oncology, St. James' University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett Street, LS9 7TF, Leeds, UK. Robin.Prestwich@nhs.net.
Leeds Teaching Hospitals NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to quantify the variation in oropharyngeal squamous cell carcinoma gross tumour volume (GTV) delineation between CT, MR and FDG PET-CT imaging.

methodsA prospective, single centre, pilot study was undertaken where 11 patients with locally advanced oropharyngeal cancers (2 tonsil, 9 base of tongue primaries) underwent pre-treatment, contrast enhanced, FDG PET-CT and MR imaging, all performed in a radiotherapy treatment mask. CT, MR and CT-MR GTVs were contoured by 5 clinicians (2 radiologists and 3 radiation oncologists). A semi-automated segmentation algorithm was used to contour PET GTVs. Volume and positional analyses were undertaken, accounting for inter-observer variation, using linear mixed effects models and contour comparison metrics respectively.

resultsSignificant differences in mean GTV volume were found between CT (11.9 cm(3)) and CT-MR (14.1 cm(3)), p < 0.006, CT-MR and PET (9.5 cm(3)), p < 0.0009, and MR (12.7 cm(3)) and PET, p < 0.016. Substantial differences in GTV position were found between all modalities with the exception of CT-MR and MR GTVs. A mean of 64 %, 74 % and 77 % of the PET GTVs were included within the CT, MR and CT-MR GTVs respectively. A mean of 57 % of the MR GTVs were included within the CT GTV; conversely a mean of 63 % of the CT GTVs were included within the MR GTV. CT inter-observer variability was found to be significantly higher in terms of position and/or volume than both MR and CT-MR (p < 0.05). Significant differences in GTV volume were found between GTV volumes delineated by radiologists (9.7 cm(3)) and oncologists (14.6 cm(3)) for all modalities (p = 0.001).

conclusionsThe use of different imaging modalities produced significantly different GTVs, with no single imaging technique encompassing all potential GTV regions. The use of MR reduced inter-observer variability. These data suggest delineation based on multimodality imaging has the potential to improve accuracy of GTV definition.

trial registrationISRCTN Registry: ISRCTN34165059 . Registered 2nd February 2015.

Indexed as

AdultAgedCarcinoma, Squamous CellFemaleFluorodeoxyglucose F18HumansMagnetic Resonance ImagingMaleMiddle AgedOropharyngeal NeoplasmsPositron-Emission TomographyTomography, X-Ray ComputedFluorodeoxyglucose F18

Identifiers

PMID26530182
PMCPMC4632362
OpenAlexW2149942242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.